← Back to headlines
Mars CEO Joins Board of GLP-1 Drug Supplier Novo Nordisk
The CEO of Mars has been appointed to a board role at Novo Nordisk, a major supplier of GLP-1 drugs, signaling a significant corporate development for the pharmaceutical company.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
